本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Akero Therapeutics

45.61
+2.575.97%
盤後46.000.3900+0.86%17:47 EDT
成交量:148.06萬
成交額:6,630.28萬
市值:36.31億
市盈率:-12.15
高:45.81
開:42.90
低:42.71
收:43.04
資料載入中...
2025/04/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/28

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report